GO:0006139 | nucleobase-containing compound metabolic process | 40.52% (47/116) | 2.0 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 37.07% (43/116) | 2.17 | 0.0 | 0.0 |
GO:0090617 | mitochondrial mRNA 5'-end processing | 7.76% (9/116) | 6.61 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 42.24% (49/116) | 1.68 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 42.24% (49/116) | 1.63 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 53.45% (62/116) | 1.26 | 0.0 | 0.0 |
GO:0090615 | mitochondrial mRNA processing | 7.76% (9/116) | 5.46 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 26.72% (31/116) | 2.16 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 42.24% (49/116) | 1.49 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 22.41% (26/116) | 2.37 | 0.0 | 0.0 |
GO:0000966 | RNA 5'-end processing | 6.9% (8/116) | 5.49 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 43.1% (50/116) | 1.38 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 57.76% (67/116) | 1.05 | 0.0 | 0.0 |
GO:0010467 | gene expression | 10.34% (12/116) | 3.96 | 0.0 | 0.0 |
GO:0000963 | mitochondrial RNA processing | 9.48% (11/116) | 4.16 | 0.0 | 0.0 |
GO:0004016 | adenylate cyclase activity | 6.9% (8/116) | 5.29 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process |
GO:0140053 | mitochondrial gene expression | 9.48% (11/116) | 4.04 | 0.0 | 0.0 |
GO:0005739 | mitochondrion | 22.41% (26/116) | 2.13 | 0.0 | 0.0 |
GO:0000959 | mitochondrial RNA metabolic process | 11.21% (13/116) | 3.45 | 0.0 | 0.0 |
GO:0009451 | RNA modification | 12.93% (15/116) | 3.04 | 0.0 | 0.0 |
GO:0080156 | mitochondrial mRNA modification | 8.62% (10/116) | 4.02 | 0.0 | 0.0 |
GO:1900864 | mitochondrial RNA modification | 9.48% (11/116) | 3.71 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 37.07% (43/116) | 1.35 | 0.0 | 0.0 |
GO:0016849 | phosphorus-oxygen lyase activity | 6.9% (8/116) | 4.31 | 0.0 | 1e-06 |
GO:0016556 | mRNA modification | 8.62% (10/116) | 3.59 | 0.0 | 1e-06 |
GO:0071704 | organic substance metabolic process | 62.07% (72/116) | 0.75 | 0.0 | 3e-06 |
GO:0009975 | cyclase activity | 6.9% (8/116) | 4.0 | 0.0 | 4e-06 |
GO:0006397 | mRNA processing | 10.34% (12/116) | 2.93 | 0.0 | 5e-06 |
GO:0016071 | mRNA metabolic process | 12.93% (15/116) | 2.37 | 0.0 | 1.7e-05 |
GO:0044237 | cellular metabolic process | 56.9% (66/116) | 0.75 | 0.0 | 2.4e-05 |
GO:0003723 | RNA binding | 20.69% (24/116) | 1.67 | 0.0 | 2.7e-05 |
GO:0043412 | macromolecule modification | 29.31% (34/116) | 1.29 | 0.0 | 3.1e-05 |
GO:0044260 | cellular macromolecule metabolic process | 24.14% (28/116) | 1.46 | 1e-06 | 4.3e-05 |
GO:1901363 | heterocyclic compound binding | 45.69% (53/116) | 0.88 | 1e-06 | 4.9e-05 |
GO:0006259 | DNA metabolic process | 12.93% (15/116) | 2.21 | 1e-06 | 5.7e-05 |
GO:0097159 | organic cyclic compound binding | 45.69% (53/116) | 0.87 | 1e-06 | 5.8e-05 |
GO:0008152 | metabolic process | 62.07% (72/116) | 0.64 | 1e-06 | 5.8e-05 |
GO:0006281 | DNA repair | 9.48% (11/116) | 2.5 | 4e-06 | 0.000261 |
GO:0032259 | methylation | 8.62% (10/116) | 2.6 | 7e-06 | 0.000386 |
GO:0043229 | intracellular organelle | 60.34% (70/116) | 0.6 | 7e-06 | 0.000401 |
GO:0043226 | organelle | 60.34% (70/116) | 0.59 | 9e-06 | 0.000493 |
GO:0009845 | seed germination | 6.9% (8/116) | 2.97 | 9e-06 | 0.0005 |
GO:0008168 | methyltransferase activity | 7.76% (9/116) | 2.64 | 1.6e-05 | 0.000834 |
GO:0006974 | cellular response to DNA damage stimulus | 10.34% (12/116) | 2.12 | 2.1e-05 | 0.001074 |
GO:0016741 | transferase activity, transferring one-carbon groups | 7.76% (9/116) | 2.59 | 2.1e-05 | 0.001085 |
GO:0000712 | resolution of meiotic recombination intermediates | 2.59% (3/116) | 5.59 | 3.3e-05 | 0.001579 |
GO:0043231 | intracellular membrane-bounded organelle | 53.45% (62/116) | 0.61 | 3.2e-05 | 0.001603 |
GO:0009987 | cellular process | 70.69% (82/116) | 0.44 | 3.8e-05 | 0.001792 |
GO:0043227 | membrane-bounded organelle | 53.45% (62/116) | 0.6 | 4.7e-05 | 0.002198 |
GO:0016829 | lyase activity | 9.48% (11/116) | 2.12 | 5e-05 | 0.002228 |
GO:0008173 | RNA methyltransferase activity | 3.45% (4/116) | 4.33 | 4.9e-05 | 0.002229 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 3.45% (4/116) | 4.31 | 5.2e-05 | 0.002274 |
GO:0051251 | positive regulation of lymphocyte activation | 3.45% (4/116) | 4.07 | 9.8e-05 | 0.004217 |
GO:0001510 | RNA methylation | 3.45% (4/116) | 4.04 | 0.000108 | 0.004558 |
GO:2001020 | regulation of response to DNA damage stimulus | 5.17% (6/116) | 2.99 | 0.000118 | 0.004836 |
GO:0006282 | regulation of DNA repair | 4.31% (5/116) | 3.41 | 0.000117 | 0.004844 |
GO:0110165 | cellular anatomical entity | 76.72% (89/116) | 0.35 | 0.000122 | 0.004906 |
GO:0002696 | positive regulation of leukocyte activation | 3.45% (4/116) | 3.95 | 0.000136 | 0.005257 |
GO:0043414 | macromolecule methylation | 6.03% (7/116) | 2.65 | 0.000135 | 0.00531 |
GO:0043073 | germ cell nucleus | 2.59% (3/116) | 4.89 | 0.000142 | 0.005436 |
GO:0050867 | positive regulation of cell activation | 3.45% (4/116) | 3.84 | 0.000183 | 0.006859 |
GO:0051249 | regulation of lymphocyte activation | 3.45% (4/116) | 3.83 | 0.00019 | 0.007031 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 9.48% (11/116) | 1.87 | 0.000224 | 0.008142 |
GO:0031156 | regulation of sorocarp development | 2.59% (3/116) | 4.62 | 0.00025 | 0.008815 |
GO:0005575 | cellular_component | 76.72% (89/116) | 0.33 | 0.000247 | 0.008838 |
GO:0061982 | meiosis I cell cycle process | 3.45% (4/116) | 3.59 | 0.000357 | 0.012408 |
GO:0008150 | biological_process | 76.72% (89/116) | 0.32 | 0.000368 | 0.012607 |
GO:0000405 | bubble DNA binding | 1.72% (2/116) | 6.07 | 0.000387 | 0.013046 |
GO:0006298 | mismatch repair | 2.59% (3/116) | 4.37 | 0.000425 | 0.014119 |
GO:0003824 | catalytic activity | 48.28% (56/116) | 0.55 | 0.000456 | 0.014522 |
GO:0045990 | carbon catabolite regulation of transcription | 2.59% (3/116) | 4.34 | 0.000451 | 0.014571 |
GO:0002694 | regulation of leukocyte activation | 3.45% (4/116) | 3.5 | 0.00045 | 0.014733 |
GO:0051054 | positive regulation of DNA metabolic process | 4.31% (5/116) | 2.92 | 0.000554 | 0.017434 |
GO:0016423 | tRNA (guanine) methyltransferase activity | 1.72% (2/116) | 5.81 | 0.000565 | 0.017535 |
GO:0050865 | regulation of cell activation | 3.45% (4/116) | 3.4 | 0.000592 | 0.018117 |
GO:0045739 | positive regulation of DNA repair | 2.59% (3/116) | 4.15 | 0.000663 | 0.020036 |
GO:1903046 | meiotic cell cycle process | 6.9% (8/116) | 2.07 | 0.000681 | 0.020328 |
GO:0045911 | positive regulation of DNA recombination | 2.59% (3/116) | 4.12 | 0.000698 | 0.020549 |
GO:0035825 | homologous recombination | 2.59% (3/116) | 4.1 | 0.000733 | 0.021334 |
GO:0031670 | cellular response to nutrient | 2.59% (3/116) | 4.05 | 0.000808 | 0.023226 |
GO:0003674 | molecular_function | 74.14% (86/116) | 0.31 | 0.000828 | 0.023491 |
GO:0009128 | purine nucleoside monophosphate catabolic process | 1.72% (2/116) | 5.49 | 0.000894 | 0.024764 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 1.72% (2/116) | 5.49 | 0.000894 | 0.024764 |
GO:1900182 | positive regulation of protein localization to nucleus | 2.59% (3/116) | 3.96 | 0.000973 | 0.026632 |
GO:2000905 | negative regulation of starch metabolic process | 1.72% (2/116) | 5.4 | 0.00102 | 0.027589 |
GO:0048296 | regulation of isotype switching to IgA isotypes | 1.72% (2/116) | 5.23 | 0.001295 | 0.033859 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.72% (2/116) | 5.23 | 0.001295 | 0.033859 |
GO:0051052 | regulation of DNA metabolic process | 6.03% (7/116) | 2.11 | 0.001283 | 0.034325 |
GO:0010212 | response to ionizing radiation | 3.45% (4/116) | 3.07 | 0.001356 | 0.035066 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 1.72% (2/116) | 5.15 | 0.001445 | 0.03576 |
GO:0001673 | male germ cell nucleus | 1.72% (2/116) | 5.15 | 0.001445 | 0.03576 |
GO:1990918 | double-strand break repair involved in meiotic recombination | 1.72% (2/116) | 5.15 | 0.001445 | 0.03576 |
GO:0009158 | ribonucleoside monophosphate catabolic process | 1.72% (2/116) | 5.15 | 0.001445 | 0.03576 |
GO:0022402 | cell cycle process | 10.34% (12/116) | 1.43 | 0.001665 | 0.039943 |
GO:0090734 | site of DNA damage | 2.59% (3/116) | 3.7 | 0.001648 | 0.040356 |
GO:0003677 | DNA binding | 17.24% (20/116) | 1.03 | 0.001665 | 0.040357 |
GO:0009125 | nucleoside monophosphate catabolic process | 1.72% (2/116) | 5.0 | 0.001767 | 0.041961 |
GO:1904894 | positive regulation of receptor signaling pathway via STAT | 1.72% (2/116) | 4.94 | 0.00194 | 0.045602 |
GO:0045191 | regulation of isotype switching | 1.72% (2/116) | 4.87 | 0.002121 | 0.048861 |
GO:0045830 | positive regulation of isotype switching | 1.72% (2/116) | 4.87 | 0.002121 | 0.048861 |